Optimising regulatory information management Pharma companies have been focused on integrating systems containing regulatory data, to automate data flows and enhance compliance. Now attention is shifting to how best to reveal interdependencies between data, documents and processes to drive efficiency and further automation. Romuald Braun, VP of Strategy for Life Sciences at Amplexor, offers some guidance to pharma businesses looking to optimise their regulatory information management (RIM) automation. Keeping on top of regulatory requirements in life sciences is a full-time occupation, as the landscape is in a constant state of flux. The new demands each year are considerable, and 2021 will be no exception. It was already set to be a big year for new compliance deadlines, and now the continuing COVID-19 pandemic is driving new urgency around streamlining and accelerating processes and shoring up data quality.